Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,972,536
-$2,630,504 QoQ
Shares Held
96,417
-62.8% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 230 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. RCUS ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in RCUS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,972,536 | 96,417 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,603,040 | 259,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,039,133 | 85,570 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $270,245 | 19,871 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $417,777 | 51,324 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $439,921 | 56,041 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $206,430 | 13,501 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $468,550 | 30,765 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,275,192 | 67,542 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $202,998 | 9,995 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $554,306 | 26,804 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $1,391,385 | 44,087 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,476,266 | 332,994 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,728,619 | 192,963 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,746,816 | 354,946 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,705,396 | 559,309 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,779,884 | 569,333 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,524,593 | 614,037 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,016,275 | 445,282 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||